The SAMRC seeks information on Electrochemiluminescence (ECL) Immunoassay Analytical Systems for research applications, focusing on high sensitivity and capability for biomarker quantification. Interested manufacturers and distributors are invited to respond.
The South African Medical Research Council (SAMRC) is inviting manufacturers, distributors, and solution providers to submit information regarding Electrochemiluminescence (ECL) Immunoassay Analytical Systems. These systems are required for high-sensitivity research applications, particularly in quantifying biomarkers such as HIV broadly neutralising antibodies (bNAbs). The RFI aims to gather comprehensive information on the technical capabilities, operational efficiencies, and support services associated with these systems to inform SAMRC's future procurement strategies.
Respondents are expected to provide detailed information on various aspects of the ECL systems, including detection sensitivity, assay capabilities (single-plex and multiplex), dynamic range specifications, and compatibility with 96-well plates. Additional requirements include software functionalities, instrument diagnostics, and compliance with quality standards. The SAMRC is particularly interested in systems that can support custom assay development and provide robust training and support options. This engagement is crucial for assessing market capacity and ensuring that the selected systems meet the rigorous demands of clinical research workflows.
This tender is suitable for manufacturers, distributors, and solution providers specializing in analytical systems, particularly those with expertise in immunoassays and high-sensitivity detection technologies for clinical research applications.
Answer a few questions — by voice, chat or a short form — and your official quote arrives as a PDF you can circulate for sign-off, ready to accept online. One fixed annual figure for your whole bid team.